Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma Group (MREO) Interest & Investment Income: 2016-2024

Historic Interest & Investment Income for Mereo BioPharma Group (MREO) over the last 9 years, with Dec 2024 value amounting to $3.0 million.

  • Mereo BioPharma Group's Interest & Investment Income fell 48.73% to $504,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 9.89%. This contributed to the annual value of $3.0 million for FY2024, which is 42.70% up from last year.
  • As of FY2024, Mereo BioPharma Group's Interest & Investment Income stood at $3.0 million, which was up 42.70% from $2.1 million recorded in FY2023.
  • Mereo BioPharma Group's 5-year Interest & Investment Income high stood at $3.0 million for FY2024, and its period low was $1,348 during FY2021.
  • For the 3-year period, Mereo BioPharma Group's Interest & Investment Income averaged around $2.0 million, with its median value being $2.1 million (2023).
  • In the last 5 years, Mereo BioPharma Group's Interest & Investment Income crashed by 97.61% in 2021 and then surged by 62,214.05% in 2022.
  • Yearly analysis of 5 years shows Mereo BioPharma Group's Interest & Investment Income stood at $56,502 in 2020, then tumbled by 97.61% to $1,348 in 2021, then spiked by 62,214.05% to $840,000 in 2022, then surged by 153.69% to $2.1 million in 2023, then soared by 42.70% to $3.0 million in 2024.